Moving beyond HLA: A review of nHLA antibodies in organ transplantation

Human Immunology

Volumn 74, Issue 11, 2013, Pages 1486-1490

  Sigdel, Tara K ^a   Sarwal, Minnie M ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; CHROMATIN ASSEMBLY FACTOR 1; ENDOTHELIAL CELL ANTIBODY; FIBROBLAST GROWTH FACTOR 2; GLUTAMATE DECARBOXYLASE ANTIBODY; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HLA A ANTIGEN; HLA ANTIBODY; HLA B ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN ANTIBODY; LAMIN B; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 2; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VIMENTIN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CARDIAC ALLOGRAFT VASCULOPATHY; CHRONIC GRAFT REJECTION; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FIBROSING ALVEOLITIS; GENE EXPRESSION; GRAFT FAILURE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG TRANSPLANTATION; MOYAMOYA DISEASE; NONHUMAN; ORGAN TRANSPLANTATION; PANCREAS INJURY; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; EPITOPE MAPPING; GRAFT REJECTION; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; ISOANTIGENS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 84885058682     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.07.001     Document Type: Article

References (52)

1. Nankivell B.J., Alexander S.I. Rejection of the kidney allograft. N Engl J Med 2010, 363(15):1451.
2. Patel R., Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969, 280(14):735.
3. Lefaucheur C., Suberbielle-Boissel C., Hill G.S., Nochy D., Andrade J., Antoine C., et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 2008, 8(2):324.
4. Terasaki P.I. A personal perspective: 100-year history of the humoral theory of transplantation. Transplantation 2012, 93(8):751.
5. Zeevi A., Lunz J., Feingold B., Shullo M., Bermudez C., Teuteberg J., et al. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant 2012, 32(1):98.
6. Zhang Q., Cecka J.M., Gjertson D.W., Ge P., Rose M.L., Patel J.K., et al. Targets of antibody-mediated rejection in heart transplantation. Transplantation 2011, 91(10):1153.
7. Li L., Chen A., Chaudhuri A., Kambham N., Sigdel T., Chen R., et al. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation. Transplantation 2010, 89(3):312.
8. Sutherland S.M., Li L., Sigdel T.K., Wadia P.P., Miklos D.B., Butte A.J., et al. Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int 2009, 76(12):1277.
9. Butte A.J., Sigdel T.K., Wadia P.P., Miklos D.B., Sarwal M.M. Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease. Mol Cell Proteomics 2011, 10(3). [M110 000497].
10. Li L., Wadia P., Chen R., Kambham N., Naesens M., Sigdel T.K., et al. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci USA 2009, 106(11):4148.
11. Sumitran-Holgersson S. Relevance of MICA and other non-HLA antibodies in clinical transplantation. Curr Opin Immunol 2008, 20(5):607.
12. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005, 365(9470):1570.
13. Sigdel T.K., Li L., Tran T.Q., Khatri P., Naesens M., Sansanwal P., et al. Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury. J Am Soc Nephrol 2012, 23(4):750.
14. Li L., Sigdel T., Vitalone M., Lee S.H., Sarwal M. Differential immunogenicity and clinical relevance of kidney compartment specific antigens after renal transplantation. J Proteome Res 2010, 9(12):6715.
15. Smith J.D., Hamour I.M., Burke M.M., Mahesh B., Stanford R.E., Haj-Yahia S., et al. A reevaluation of the role of IgM non-HLA antibodies in cardiac transplantation. Transplantation 2009, 87(6):864.
16. Le Bas-Bernardet S., Hourmant M., Coupel S., Bignon J.D., Soulillou J.P., Charreau B. Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant 2003, 3(2):167.
17. Hourmant M., Buzelin F., Dantal J., van Dixhoorn M., Le Forestier M., Coste M., et al. Late acute failure of well-HLA-matched renal allografts with capillary congestion and arteriolar thrombi. Transplantation 1995, 60(11):1252.
18. Terasaki P.I. Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants. Clin Transpl 2003, 449.
19. Ranganath P., Tripathi G., Sharma R.K., Sankhwar S.N., Agrawal S. Role of non-HLA genetic variants in end-stage renal disease. Tissue Antigens 2009, 74(2):147.
20. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011, 17(5):610.
21. Naesens M., Khatri P., Li L., Sigdel T.K., Vitalone M.J., Chen R., et al. Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int 2011, 80(12):1364.
22. Sigdel T.K., Shoemaker L.D., Chen R., Li L., Butte A.J., Sarwal M.M., et al. Immune response profiling identifies autoantibodies specific to Moyamoya patients. Orphanet J Rare Dis 2013, 8:45.
23. Bilalic S., Veitinger M., Ahrer K.H., Gruber V., Zellner M., Brostjan C., et al. Identification of non-HLA antigens targeted by alloreactive antibodies in patients undergoing chronic hemodialysis. J Proteome Res 2010, 9(2):1041.
24. Naesens M., Kambham N., Concepcion W., Salvatierra O., Sarwal M. The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients. Am J Transplant 2007, 7(11):2504.
25. Kambham N., Nagarajan S., Shah S., Li L., Salvatierra O., Sarwal M.M. A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. Clin J Am Soc Nephrol 2007, 2(1):135.
26. Sarwal M.M., Ettenger R.B., Dharnidharka V., Benfield M., Mathias R., Portale A., et al. Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up. Am J Transplant 2012, 12(10):2719.
27. Grandtnerova B., Laca L., Jahnova E., Horvathova M., Balaz V., Hovoricova B., et al. Hyperacute rejection of living related kidney graft caused by IgG endothelial specific antibodies with a negative monocyte cross-match. Ann Transplant 2002, 7(4):52.
28. Grandtnerova B., Mackova N., Hovoricova B., Jahnova E. Hyperacute rejection of living related kidney grafts caused by endothelial cell-specific antibodies: case reports. Transplant Proc 2008, 40(7):2422.
29. Perrey C., Brenchley P.E., Johnson R.W., Martin S. An association between antibodies specific for endothelial cells and renal transplant failure. Transpl Immunol 1998, 6(2):101.
30. Jackson A.M., Lucas D.P., Melancon J.K., Desai N.M. Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood. Transplantation 2011, 92(1):54.
31. Fredrich R., Toyoda M., Czer L.S., Galfayan K., Galera O., Trento A., et al. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation 1999, 67(3):385.
32. Breimer M.E., Rydberg L., Jackson A.M., Lucas D.P., Zachary A.A., Melancon J.K., et al. Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation 2009, 87(4):549.
33. Dragun D., Muller D.N., Brasen J.H., Fritsche L., Nieminen-Kelha M., Dechend R., et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005, 352(6):558.
34. Narayan S., Tsai E.W., Zhang Q., Wallace W.D., Reed E.F., Ettenger R.B. Acute rejection associated with donor-specific anti-MICA antibody in a highly sensitized pediatric renal transplant recipient. Pediatr Transplant 2011, 15(1):E1.
35. Zou Y., Stastny P. Antibodies against major histocompatibility complex class I-related chain A in transplant recipients. Chin Med J (Engl) 2011, 124(5):764.
36. Chaudhuri A., Ozawa M., Everly M.J., Ettenger R., Dharnidharka V., Benfield M., et al. The clinical impact of humoral immunity in pediatric renal transplantation. J Am Soc Nephrol 2013, 24(4):655.
37. Sumitran-Holgersson S., Ge X., Karrar A., Xu B., Nava S., Broome U., et al. A novel mechanism of liver allograft rejection facilitated by antibodies to liver sinusoidal endothelial cells. Hepatology 2004, 40(5):1211.
38. Nath D.S., Ilias Basha H., Tiriveedhi V., Alur C., Phelan D., Ewald G.A., et al. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy. J Heart Lung Transplant 2010, 29(11):1277.
39. Kalache S., Dinavahi R., Pinney S., Mehrotra A., Cunningham M.W., Heeger P.S. Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients. J Immunol 2011, 187(2):1023.
40. Acevedo M.J., Caro-Oleas J.L., Alvarez-Marquez A.J., Sobrino J.M., Lage-Galle E., Aguilera I., et al. Antibodies against heterogeneous nuclear ribonucleoprotein K in patients with cardiac allograft vasculopathy. J Heart Lung Transplant 2011, 30(9):1051.
41. Jaramillo A., Naziruddin B., Zhang L., Reznik S.I., Smith M.A., Aloush A.A., et al. Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome. Transplantation 2001, 71(7):966.
42. Goers T.A., Ramachandran S., Aloush A., Trulock E., Patterson G.A., Mohanakumar T. De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol 2008, 180(7):4487.
43. Tiriveedhi V., Gelman A.E., Mohanakumar T. HIF-1alpha signaling by airway epithelial cell K-alpha1-tubulin: role in fibrosis and chronic rejection of human lung allografts. Cell Immunol 2012, 273(1):59.
44. Burlingham W.J., Love R.B., Jankowska-Gan E., Haynes L.D., Xu Q., Bobadilla J.L., et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007, 117(11):3498.
45. Tiriveedhi V., Angaswamy N., Brand D., Weber J., Gelman A.G., Hachem R., et al. A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection. Clin Exp Immunol 2012, 167(1):158.
46. Wadia P.P., Coram M., Armstrong R.J., Mindrinos M., Butte A.J., Miklos D.B. Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation. Blood 2010, 115(10):2077.
47. Dinavahi R., George A., Tretin A., Akalin E., Ames S., Bromberg J.S., et al. Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol 2011, 22(6):1168.
48. Sarwal M.M., Sigdel T.K., Salomon D.R. Functional proteogenomics-embracing complexity. Semin Immunol 2011, 23(4):235.
49. Sun Q., Cheng Z., Cheng D., Chen J., Ji S., Wen J., et al. De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection. Kidney Int 2010, 79(6):655.
50. Ismail A.M., Badawi R.M., El-Agroudy A.E., Mansour M.A. Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome. Exp Clin Transplant 2009, 7(2):104.
51. Otten H.G., van den Bosch J.M., van Ginkel W.G., van Loon M., van de Graaf E.A. Identification of non-HLA target antigens recognized after lung transplantation. J Heart Lung Transplant 2006, 25(12):1425.
52. Porcheray F., Wong W., Saidman S.L., De Vito J., Girouard T.C., Chittenden M., et al. B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant 2009, 9(9):2126.